Assessing the cost effectiveness of adjuvant therapies in early breast cancer using a decision analysis model Bruce E. HillnerThomas J. SmithChristopher E. Desch Cost analysis of diagnosis and treatment in breast cancer — Mini-symposium Pages: 97 - 105
Breast cancer surveillance — a cost-effective strategy David V. Schapira Cost analysis of diagnosis and treatment in breast cancer — Mini-symposium Pages: 107 - 111
Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature Martin L. BrownLou Fintor Cost analysis of diagnosis and treatment in breast cancer — Mini-symposium Pages: 113 - 118
Payment and coverage issues affecting medical oncology Joseph S. Bailes Cost analysis of diagnosis and treatment in breast cancer — Mini-symposium Pages: 119 - 126
Predicting recurrence in axillary-node negative breast cancer patients Dutzu RosnerWarren W. Lane Report Pages: 127 - 139
Human recombinant interferon-βSER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse David F. C. GibsonDelinda A. JohnsonV. Craig Jordan Report Pages: 141 - 150
Mechanisms involved in the metastasis of cancer to bone F. William OrrPaul KostenuikGurmit Singh Breast Cancer Metastases — from Genome to Therapy (Mini-symposium) Pages: 151 - 163
Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma S. D. PencilY. TohG. L. Nicolson Breast Cancer Metastases — from Genome to Therapy (Mini-symposium) Pages: 165 - 174
Nm23 and breast cancer metastasis Patricia S. SteegAbel De La RosaAlvaro Leone Breast Cancer Metastases — from Genome to Therapy (Mini-symposium) Pages: 175 - 187